| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. | Chief Financial Officer | Common Stock | 55,950 | 11 Apr 2025 | Direct | ||
| Kyverna Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 2,192 | 28 May 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | 11 Apr 2025 | 2 | $0 | 4 | Chief Financial Officer | 15 Apr 2025, 17:42 |
| KYTX | Kyverna Therapeutics, Inc. | 28 May 2024 | 4 | +$13,152 | 4 | Chief Financial Officer | 29 May 2024, 16:33 |
| KYTX | Kyverna Therapeutics, Inc. | 07 Feb 2024 | 0 | $0 | 3 | Chief Financial Officer | 07 Feb 2024, 21:56 |